var path='https://www.tickertech.net'; function heading(heading) { document.write('
'+heading+' |
'+ ''+ ' |
'); } function hiLite(imgDocID,imgObjName) { document.images[imgDocID].src = eval(imgObjName + ".src"); } function showStatus(toshow) { window.status = toshow; } function checkChoose() { if (document.choose.ticker.value == "") { alert("Please enter symbols before clicking the go button"); return false; } else return true; } function popJT(url,name){ var xwid = screen.width; xwid = xwid - 10; javaticker = window.open(url,name,'width='+xwid+',height=100,resizable=yes,scrollbars=no,toolbar=no,location=no,directories=no,status=yes,menubar=no'); javaticker.opener.name="opener"; //javaticker.moveTo(0,30); } var allow = 0; var ref = ""+location; if ((ref.indexOf("cryptocurrencieschannel.com") > 0) || (ref.indexOf("cefchannel.com") > 0) || (ref.indexOf("bdcinvestor.com") > 0) || (ref.indexOf("tickertech.com") > 0) || (ref.indexOf("xxxx:") > 0) || (ref.indexOf("javascript:") > 0) || (ref.indexOf("filseclab.com") > 0) || (ref.indexOf("msnscache.com") > 0) || (ref.indexOf("toolbar.google.com") > 0) || (ref.indexOf("etfchannel.com") > 0) || (ref.indexOf("marketnewsvideo.com") > 0) || (ref.indexOf("news.google.com") > 0) || (ref.indexOf("dividendchannel.com") > 0) || (ref.indexOf("www.google.com") > 0) || (ref.indexOf("energystockchannel.com") > 0) || (ref.indexOf("metalschannel.com") > 0) || (ref.indexOf("portfoliochannel.com") > 0) || (ref.indexOf("canadastockchannel.com") > 0) || (ref.indexOf("theonlineinvestor.com") > 0) || (ref.indexOf("investhelp.com") > 0) || (ref.indexOf("preferredstockchannel.com") > 0) || (ref.indexOf("stockoptionschannel.com") > 0) || (ref.indexOf("holdingschannel.com") > 0) || (ref.indexOf("tickertech.net") > 0) || (ref.indexOf("historicalstockprice.com") > 0) || (ref.indexOf("splithistory.com") > 0) || (ref.indexOf("stocksplithistory.com") > 0) || (ref.indexOf("google.c") > 0) || (ref.indexOf("208.71.46.190") > 0) || (ref.indexOf("search.yahoo") > 0) || (ref.indexOf("sharesoutstandinghistory.com") > 0) || (ref.indexOf("marketcaphistory.com") > 0) || (ref.indexOf("ytdreturn.com") > 0) || (ref.indexOf("averageannualreturn.com") > 0) || (ref.indexOf("redinews.com") > 0) || (ref.indexOf("technicalanalysischannel.com") > 0) || (ref.indexOf("stockdma.com") > 0) || (ref.indexOf("stockrsi.com") > 0) || (ref.indexOf("stockmacd.com") > 0) || (ref.indexOf("topdividends.com") > 0) || (ref.indexOf("monthlydividendpayingstocks.com") > 0) || (ref.indexOf("nextearningsdate.com") > 0) || (ref.indexOf("pastearnings.com") > 0) || (ref.indexOf("historicalperatio.com") > 0) || (ref.indexOf("historicalearnings.com") > 0) || (ref.indexOf("webcache.googleusercontent.com") > 0)) { allow = 1; } function ShowTTIPage() { if (allow) { document.write('\n'); } if (allow) { document.write('
\; Detailed Quotes - AZN | \n'); } if (allow) { document.write('Saturday, May 4, 6:26 AM\n'); } if (allow) { document.write(' |
\n'); } if (allow) { document.write('
Look under \'\'More Info\'\' for further information. At least 20 min. delay. | \n'); } if (allow) { document.write(' \; | \n'); } if (allow) { document.write('
\n'); }
if (allow) { document.write(' Astrazeneca Plc - American Depositary SH (NASD: AZN)\n'); }
if (allow) { document.write(' \n'); } if (allow) { document.write('More Info: \n'); } if (allow) { document.write('chart  \;comp profile  \;stock screen  \;news  \;www.astrazeneca.com \n'); } if (allow) { document.write(' ValueForum rating\n'); } if (allow) { document.write(' \n'); } if (allow) { document.write('\n'); } if (allow) { document.write(' | \n'); }
if (allow) { document.write('||||||
Last Trade 4:00 p.m. - 76.37 | \n'); }
if (allow) { document.write('Change  \;0.57 ( \;0.75%) | \n'); }
if (allow) { document.write('Trades Today 66,219 | \n'); }
if (allow) { document.write('Day\'s Volume 9,026,349 | \n'); }
if (allow) { document.write('|||
Beta 0.5523 | \n'); }
if (allow) { document.write('Day\'s Range 75.43 - 76.49 | \n'); }
if (allow) { document.write('Prev Close 75.80 | \n'); }
if (allow) { document.write('Open 76.47 | \n'); }
if (allow) { document.write('52 Wk Range 60.47 - 76.80 | \n'); }
if (allow) { document.write('||
EPS 1.905 | \n'); }
if (allow) { document.write('PE 37.71 | \n'); }
if (allow) { document.write('Semi-annual Div/Shr 0.985 | \n'); }
if (allow) { document.write('Ex-Div 02/22/24 | \n'); }
if (allow) { document.write('Yield 2.58% | \n'); }
if (allow) { document.write('Shares Out. 3.10B | \n'); }
if (allow) { document.write('Market Cap. 236.78B | \n'); }
if (allow) { document.write('
\n'); } if (allow) { document.write(' \; \;\; \;1 Year Stock Performance: \; \; \;\n'); } if (allow) { document.write(' | \n'); } if (allow) { document.write('||||||
\n'); } var SC_width= "549"; var SC_height= "274"; var SC_clientId = "etfchannel"; var SC_type= "line"; var SC_period = "1y"; var SC_chartBackgroundColor= "FFFFFF"; var SC_gridLocation= "background"; var SC_labelSide = "left"; var SC_gridBackgroundColor= "F6F6F6"; var SC_gridColor= "CCCCCC"; var SC_axisColor= "222222"; var SC_symbols= "AZN"; var SC_showHighsLows= "no"; var SC_movingAverages= "no"; var SC_movingAverageColors = "FF8800,009900"; var SC_symbolLabels= "yes"; var SC_lineThicknesses= "1"; var SC_lineColors= "222222,AD0000,00FF00,DE6E00,ACA715,3C86AC,AC009A,FF0000,07AD80,1400AC"; var SC_showPrevClose= "no"; var SC_prevCloseColor= "600000"; var SC_fillBelowLine = "yes"; var SC_fillColor= "89D48C"; var SC_fillColor2= "89D48C"; var SC_smoothChart= "yes"; var SC_smoothFonts= "yes"; var SC_fontFace= "Arial"; var SC_fontSize= "2"; var SC_labelColor= "222222"; var SC_bottomLabels= ""; var SC_beforeLeftLabels= escape(''); var SC_afterLeftLabels= escape(''); var SC_leftLabelsEvery= "12"; var SC_leftBuffer= "35"; var SC_rightBuffer= "55"; var SC_bottomBuffer= "25"; var SC_bottomTableHeight= "30"; var SC_showVolumeTable= "yes"; var SC_showLegendTable = "no"; var SC_volumeColor= "222222"; document.write(''); if (allow) { document.write('\n'); } if (allow) { document.write(' | \n'); } if (allow) { document.write('
\n'); } if (allow) { document.write(' | \n'); } if (allow) { document.write(' | \n'); } if (allow) { document.write(' | \n'); } if (allow) { document.write('\n'); } if (allow) { document.write(' |
 \;symbol lookup \; | \n'); } if (allow) { document.write(' \; Find more stocks like \; | \n'); } if (allow) { document.write('\n'); } if (allow) { document.write(' | \n'); } if (allow) { document.write(' | \n'); } if (allow) { document.write(' |
5/2 - 7:00 AM \; \; | \n'); } if (allow) { document.write('CALQUENCE combination regimen demonstrated statistically significant and clinically meaningful improvement in progression-free survival in 1st-line mantle cell lymphoma in ECHO Phase III trial | \n'); } if (allow) { document.write('
5/1 - 7:05 AM \; \; | \n'); } if (allow) { document.write('AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio | \n'); } if (allow) { document.write('
4/29 - 7:00 AM \; \; | \n'); } if (allow) { document.write('ENHERTU (fam-trastuzumab deruxtecan-nxki) improved PFS in HER2-low and ultralow | \n'); } if (allow) { document.write('
4/29 - 2:00 AM \; \; | \n'); } if (allow) { document.write('ENHERTU Demonstrated Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in HR Positive, HER2 Low Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy in DESTINY-Breast06 Phase 3 Trial | \n'); } if (allow) { document.write('
4/25 - 10:58 AM \; \; | \n'); } if (allow) { document.write('Nasdaq 100 Movers: META, AZN [VIDEO] | \n'); } if (allow) { document.write('
4/25 - 8:06 AM \; \; | \n'); } if (allow) { document.write('AbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting | \n'); } if (allow) { document.write('
4/25 - 2:00 AM \; \; | \n'); } if (allow) { document.write('Q1 2024 results | \n'); } if (allow) { document.write('
4/16 - 8:00 AM \; \; | \n'); } if (allow) { document.write('Asher Bio Closes $55 Million Series C Financing to Advance Lead Program into Phase 1b Clinical Trials | \n'); } if (allow) { document.write('
4/16 - 7:00 AM \; \; | \n'); } if (allow) { document.write('IMFINZI (durvalumab) plus chemotherapy doubled overall survival rate at three years for patients with advanced biliary tract cancer in TOPAZ-1 Phase III trial | \n'); } if (allow) { document.write('
4/11 - 7:00 AM \; \; | \n'); } if (allow) { document.write('FASENRA approved for treatment of children aged 6 to 11 with severe asthma | \n'); } if (allow) { document.write('
4/5 - 11:10 PM \; \; | \n'); } if (allow) { document.write('ENHERTU Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2 Positive Solid Tumors | \n'); } if (allow) { document.write('
4/5 - 9:43 PM \; \; | \n'); } if (allow) { document.write('ENHERTU (fam-trastuzumab deruxtecan-nxki) approved in the US as first tumor-agnostic HER2-directed therapy for previously treated patients with metastatic HER2-positive solid tumors | \n'); } if (allow) { document.write('
4/5 - 7:00 AM \; \; | \n'); } if (allow) { document.write('IMFINZI (durvalumab) significantly improved overall survival and progression-free survival for patients with limited-stage small cell lung cancer in ADRIATIC Phase III trial | \n'); } if (allow) { document.write('
4/2 - 7:00 AM \; \; | \n'); } if (allow) { document.write('Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated metastatic HR-positive, HER2-negative breast cancer | \n'); } if (allow) { document.write('
4/2 - 2:00 AM \; \; | \n'); } if (allow) { document.write('Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer | \n'); } if (allow) { document.write('
more news | \n'); } if (allow) { document.write('\n'); } if (allow) { document.write(' | \n'); } if (allow) { document.write('
\n'); } if (allow) { document.write('
\n'); } if (allow) { document.write(' | |
\n'); } if (allow) { document.write(' | \n'); } if (allow) { document.write(' \n'); } if (allow) { document.write(' Private-label branded pages powered by TickerTech.com. \n'); } if (allow) { document.write(' Copyright ©\; 2024 Ticker Technologies, \n'); } if (allow) { document.write('All Rights Reserved. Quote data is at least 20 minutes delayed. \n'); } if (allow) { document.write('NYMEX data is at least 30 minutes delayed. Please read other important \n'); } if (allow) { document.write(' disclaimer information.\n'); } if (allow) { document.write(' | \n'); } if (allow) { document.write('